Global Coalition for Adaptive Research's Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer

The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week.